Tonix Pharmaceuticals Holding Corp.

12/29/2025 | Press release | Distributed by Public on 12/29/2025 15:19

TNX-4800 A Novel Monoclonal Antibody for the Prevention of Lyme Disease

Tonix Pharmaceuticals Holding Corp. published this content on December 29, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 29, 2025 at 21:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]